IJR vs VHT
iShares Core S&P Small-Cap ETF vs Vanguard Health Care ETF
- • IJR has the lower expense ratio at 0.06% vs 0.09% for VHT.
- • VHT pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | IJR | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.16% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $102.56B | $18.51B |
YTD return | 15.78% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.17 | 0.64 |
P/E ratio | 18.30 | 25.44 |
Last price | $137.64 | $271.09 |
Inception | — | — |
Issuer | iShares | Vanguard |
IJR top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 1.44% |
| VIAV | Viavi Solutions Inc | 0.72% |
| SANM | Sanmina Corp | 0.71% |
| FORM | FormFactor Inc | 0.63% |
| MOH | Molina Healthcare Inc | 0.60% |
| PRIM | Primoris Services Corp | 0.58% |
| SMTC | Semtech Corp | 0.58% |
| ESI | Element Solutions Inc | 0.58% |
| AGX | Argan Inc | 0.55% |
| VSAT | Viasat Inc | 0.53% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About IJR
IJR (iShares Core S&P Small-Cap ETF) is Tracks the S&P SmallCap 600 index. Managed by iShares, the fund carries $102.6B in assets under management, an expense ratio of 0.06%, a dividend yield of 1.16%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 7.6%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.